Wednesday, July 19, 2017 9:32:35 AM
JULY 19TH, 2017
Hepatitis C pipeline drugs review h1 2017 latest report provides Hepatitis C therapeutics development by key players including AbbVie, Merck, Gilead, Novartis and other 65 key players which are discussed in report.
Hepatitis C Pipeline Therapeutics and Drugs Development Review H1 2017 report reviews of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. The guide covers Hepatitis C Therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 13, 23, 15, 1, 52, 45 and 4 respectively. Similarly, the Universities portfolio in Phase II, IND/CTA Filed, Preclinical and Discovery stages comprises 3, 1, 9 and 23 molecules, respectively. Hepatitis C is a contagious viral infection affecting the liver. It may spread on contact with infected blood. It may be a mild condition or may extend over a longer span of time leading to various complications. Pharmaceutical and Healthcare latest pipeline guide Hepatitis C – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hepatitis C (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Get Discount on report at http://www.reportsnreports.com/contacts/discount.aspx?name=983987 .
Companies involved in Hepatitis C Pipeline Therapeutics and Drugs Development analysed are ... MultiCell Technologies Inc ...
https://www.medgadget.com/2017/07/hepatitis-c-pipeline-drugs-and-therapeutics-market-2017.html
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM